The biopharmaceutical company employs 5,000 people in Valais, and also announced a 15% sales growth in 2022, representing a total…

The three partners secured a €1 million ($1.1 million) in Eurostars grant funding to develop a first of a king…

Listen to Magali Bischof, BioAlps Secretary General, on Beyond Biotech podcast speaking about the Swiss Health Valley and the role…

A breakthrough in the fight against cancer: researchers from EPFL, the Ludwig Institute of the CHUV, the SIB, and Roche…

The new Centre for Virtual Medicine at the HUG is a pioneer in the use of virtual reality for clinical…

The Swiss-based startup builds devices to automate processes in Life Science research and prepares a product rollout and expansion.  …

MachineMD, a spin-off of Inselspital Bern, and CSEM, are collaborating to diagnose brain diseases by analyzing eye movements with a…

Neurosoft Bioelectronics SA, a startup developing implantable brain-computer interfaces, announces that it has received ISO 13485:2016 Certification by TÜV SÜD…

The contract covers the delivery of a large volume of peptides over a five-year period from 2025-2029, and follows the…

MPC Therapeutics (MPC Tx), is a Swiss biotechnology company based in Geneva, focusing on metabolism and cellular rejuvenation.   The…

ten23 health®, a global contract development and manufacturing organization (CDMO) announces the change in branding of its in Visp, Switzerland…

The transaction with Novartis reinforces STALICLA’s position as the leading developer of precision medicines for neurodevelopmental disorders and heralds the…